FindTrial
Sign In

A study to evaluate the safety and efficacy of two different doses of oxytocin bolus doses in elective caesarean sections.

A comparative study to evaluate the safety and efficacy of two different doses of oxytocin boluses in elective caesarean sections.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042453
Enrollment
104
Registered
2022-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: Comparision of the safety and efficacy of two different doses of oxytocin boluses in elective caesarean sections.: Group 1 : patients will receive 1 unit of oxytocin bolus follo

Sponsors

Department of Anaesthesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade II, Elective LSCS under Spinal Anaesthesia, Singleton pregnancy

Exclusion criteria

Exclusion criteria: • Refusal of patient • Emergency LSCS • History of allergy to oxytocin • Placenta previa/accreta • Polyhydramnios • >2 Previous Caesarean sections • Multifetal Pregnancy • Contra-indications for Spinal Anaesthesia • Inadequate Spinal Anaesthesia or conversion to General Anaesthesia

Design outcomes

Primary

MeasureTime frame
â?? To compare changes in HR and MAP (hemodynamic changes) that occur after administration of 1 and 3 units of iv oxytocin bolus.Timepoint: Intra operative period after spinal anaesthesia—

Secondary

MeasureTime frame
â?? To study the adequacy of utrerine contractions achieved by two different doses of oxytocin boluses. â?? Adverse effects that occur. â?? Requirement of additional uterotonic agents. Timepoint: Intra operative period after spinal anaesthesia—

Countries

India

Contacts

Public ContactSapna Bansal

MM Institute of Medical Sciences

drsapna10@gmail.com8168381441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026